Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Literature
1.
Yang CJ, Lee JY, Wu CC, Yin HL, Lien CT, Liu YC (2012) An unusual pulmonary mass with mediastinal invasion and multiple intrapulmonary nodules in a 52-year-old man. Chest 141(1):253–258CrossRefPubMed
2.
Wang YN, Zhou XG, Wang Z (2013) Langerhans cell sarcoma in the cervical lymph node: a case report and literature review. Acta Haematol 129(2):114–120CrossRefPubMed
3.
Valentín-Nogueras SM, Seijo-Montes R, Montalván-Miró E, Sánchez JL (2013) Langerhans cell sarcoma: a case report. J Cutan Pathol 40(7):670–675CrossRefPubMed
4.
Sagransky MJ, Deng AC, Magro CM (2013) Primary cutaneous Langerhans cell sarcoma: a report of four cases and review of the literature. Am J Dermatopathol 35(2):196–204CrossRefPubMed
5.
Pileri SA, Grogan TM, Harris NL et al (2002) Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41(1):1–29CrossRefPubMed
6.
Kawase T, Hamazaki M, Ogura M et al (2005) CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases. Int J Hematol 81(4):323–329CrossRefPubMed
7.
Yoshimi A, Kumano K, Motokura T et al (2008) ESHAP therapy effective in a patient with Langerhans cell sarcoma. Int J Hematol 87(5):532–537CrossRefPubMed
8.
9.
Uchida K, Kobayashi S, Inukai T et al (2008) Langerhans cell sarcoma emanating from the upper arm skin: Successful treatment by MAID regimen. J Orthop Sci 13(1):89–93CrossRefPubMed
10.
Maki RG, Wathen JK, Patel SR et al (2007) Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol 25(19):2755–2763CrossRefPubMed
Metadata
Title
Cutaneous Langerhans cell sarcoma relapsing systemically: Complete remission with the EPIG regimen
Author
Yok-Lam Kwong
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2203-0

Other articles of this Issue 4/2015

Annals of Hematology 4/2015 Go to the issue

Original Article

Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial

Original Article

Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry

Original Article

L-carnitine effectively improves the metabolism and quality of platelet concentrates during storage

Original Article

Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?

Original Article

Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with l-asparaginase-containing chemotherapy—a single institution experience

Original Article

Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits